Oluf Dimitri Røe

About Oluf Dimitri Røe

Oluf Dimitri Røe, With an exceptional h-index of 30 and a recent h-index of 22 (since 2020), a distinguished researcher at Norges teknisk-naturvitenskaplige universitet, specializes in the field of Cancer research.

His recent articles reflect a diverse array of research interests and contributions to the field:

Improving Lung Cancer Screening Selection: The HUNT Lung Cancer Risk Model for Ever-Smokers Versus the NELSON and 2021 United States Preventive Services Task Force Criteria in …

BAP1, Wilms’ tumor 1, and calretinin in predicting survival and response to first-line chemotherapy in patients with pleural mesothelioma

Clinical aspects in translational research on gastric tumorigenesis and development of new treatments

B. Malignant Pleural Mesothelioma

Prediction of 6-year risk of bladder cancer using the HUNT Lung Cancer Risk Model in ever-smokers: A HUNT study.

Baseline Serum Prostate-specific Antigen Value Predicts the Risk of Subsequent Prostate Cancer Death—Results from the Norwegian Prostate Cancer Consortium

Increased levels of microRNA‐320 in blood serum and plasma is associated with imminent and advanced lung cancer

Diagnostic capacity of BAP1 and MTAP in cytology from effusions and biopsy in mesothelioma

Oluf Dimitri Røe Information

University

Position

MD PhD Norway

Citations(all)

2857

Citations(since 2020)

1407

Cited By

2083

hIndex(all)

30

hIndex(since 2020)

22

i10Index(all)

54

i10Index(since 2020)

43

Email

University Profile Page

Google Scholar

Oluf Dimitri Røe Skills & Research Interests

Cancer research

Top articles of Oluf Dimitri Røe

Improving Lung Cancer Screening Selection: The HUNT Lung Cancer Risk Model for Ever-Smokers Versus the NELSON and 2021 United States Preventive Services Task Force Criteria in …

JTO Clinical and Research Reports

2024/4/1

BAP1, Wilms’ tumor 1, and calretinin in predicting survival and response to first-line chemotherapy in patients with pleural mesothelioma

Journal of cancer research and clinical oncology

2024/1/27

Clinical aspects in translational research on gastric tumorigenesis and development of new treatments

Proceeding of the Shevchenko Scientific Society. Medical Sciences

2023/12/22

Oluf Dimitri Røe
Oluf Dimitri Røe

H-Index: 21

Duan Chen
Duan Chen

H-Index: 9

B. Malignant Pleural Mesothelioma

2023/10/4

Muzaffer Metintaş
Muzaffer Metintaş

H-Index: 22

Oluf Dimitri Røe
Oluf Dimitri Røe

H-Index: 21

Prediction of 6-year risk of bladder cancer using the HUNT Lung Cancer Risk Model in ever-smokers: A HUNT study.

2023/6/1

Baseline Serum Prostate-specific Antigen Value Predicts the Risk of Subsequent Prostate Cancer Death—Results from the Norwegian Prostate Cancer Consortium

European Urology

2023/5/9

Increased levels of microRNA‐320 in blood serum and plasma is associated with imminent and advanced lung cancer

Molecular Oncology

2023/2

Diagnostic capacity of BAP1 and MTAP in cytology from effusions and biopsy in mesothelioma

Journal of the American Society of Cytopathology

2022/11/1

Oluf Dimitri Røe
Oluf Dimitri Røe

H-Index: 21

Common MicroRNAs in Pre-diagnostic Serum Associated with Lung Cancer in Two Cohorts up to Eight Years Before Diagnosis: A HUNT Study

2022/9/8

MA11. 04 Genetic Variants of HUNT Lung Cancer Model Improve Lung Cancer Risk Assessment Over Clinical Models

Journal of Thoracic Oncology

2022/9/1

EP01. 01-005 Increased Levels of mRNAs and miRNAs Associated with Imminent and Advanced Lung Cancer

Journal of Thoracic Oncology

2022/9/1

EP01. 01-009 Common MicroRNAs in Pre-diagnostic Serum Associated with Lung Cancer in Two Cohorts up to Eight Years Before Diagnosis: A HUNT Study

Journal of Thoracic Oncology

2022/9/1

A nomogram to predict survival probability of gastric cancer patients undergoing radical surgery and adjuvant chemotherapy

Frontiers in Oncology

2022/8/5

Response to “Revisiting ‘BAP1ness’ in Malignant Pleural Mesothelioma”

Journal of Thoracic Oncology

2022/8/1

Oluf Dimitri Røe
Oluf Dimitri Røe

H-Index: 21

Corrigendum to “A validated clinical risk prediction model for lung cancer in smokers of all ages and exposure types: A HUNT study”[EBioMedicine 31 (2018) 36–46]

EBioMedicine

2022/8/1

BAP1 loss by immunohistochemistry predicts improved survival to first-line platinum and pemetrexed chemotherapy for patients with pleural mesothelioma: a validation study

Journal of Thoracic Oncology

2022/7/1

Oluf Dimitri Røe
Oluf Dimitri Røe

H-Index: 21

Long-term predictive value of serum PSA values obtained in clinical practice: Results from the Norwegian Prostate Cancer Consortium (NPCC).

2022/6/1

A cohort study on cancer incidence among women exposed to environmental asbestos in childhood with a focus on female cancers, including breast cancer

International journal of environmental research and public health

2022/2/13

Oluf Dimitri Røe
Oluf Dimitri Røe

H-Index: 21

Adjuvant platinum-based chemotherapy in non-small cell lung cancer: The role of relative dose-intensity and treatment delay

Cancer treatment and research communications

2021/1/1

Martin Bøgsted
Martin Bøgsted

H-Index: 22

Oluf Dimitri Røe
Oluf Dimitri Røe

H-Index: 21

Cancer incidence and risk of multiple cancers after environmental asbestos exposure in childhood—A long-term register-based cohort study

International journal of environmental research and public health

2021/12/27

Oluf Dimitri Røe
Oluf Dimitri Røe

H-Index: 21

See List of Professors in Oluf Dimitri Røe University(Norges teknisk-naturvitenskaplige universitet)

Co-Authors

academic-engine